Approval · Notice of Compliance 25979 · 2021
AVAXIM: Notice of Compliance 25979
Issued June 2, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25979
- Date
- June 2, 2021
- Company
- Sanofi Pasteur LimitedSwiftwater, Pennsylvania, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product monograph update
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AVAXIM | Not yet assigned | — |
Medicinal ingredients
- HEPATITIS A VACCINE, INACTIVATED 160 UNIT per 0.5ML
- HEPATITIS A VACCINE, INACTIVATED 80 UNIT per 0.5ML